Aquestive Therapeutics Receives Conditional FDA Acceptance of Anaphylm Proprietary Identify for Lead Candidate AQST-109 (Epinephrine Sublingual Movie)
WARREN, NJ, April 20, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the Firm or Aquestive), a pharmaceutical firm that advances medicines to resolve affected person issues with present …
Aquestive Therapeutics Receives Conditional FDA Acceptance of Anaphylm Proprietary Identify for Lead Candidate AQST-109 (Epinephrine Sublingual Movie) Read More